Professional peptide High Purity CAS 16960-16-0 Cosyntropin (Tetrakosaktid) with Safe Delivery
- Hersteller: Dewael
- Produkttest: 99%+
- Aussehen:White lyophilized powder
- Herkunftsort: China
- Zertifizierung: SGS,ISO9001, GMP
- Mindestbestellmenge: 100ml
- Verpackungsinformationen: Diskreter Möglichkeiten der Verpackung für den Zoll garantiert
- Lieferzeit: Innerhalb 12 Stunden nach Eingang Ihrer Zahlung
- Zahlungsbedingungen: Western Union, Moneygram,Bitcoin,Banküberweisung
- Versand: EMS,DHL,Fedex,UPS,TNT und so weiter.
- Politik: Re-Schifffahrtspolitik
- Lieferfähigkeit: 500-600Liter / Monat
Professional peptide High Purity CAS 16960-16-0 Cosyntropin with Safe Delivery
Grundlegende Informationen:
Produktname:Tetrakosaktid,Cosyntropin,Tetracosactrin,acortan
Reinheit: 99%
CAS Registry Number: 16960-16-0
Einecs Nr: 241-031-1
MF: C136H210N40O31S
MW: 2933.47
Schmelzpunkt: 2 ° C
Boiling point: 225° C
Refractive index: 1.551-1.553
Aussehen: Colorless transparent liquid
Klasse: Pharmceutical Grade
Lager: Schattierung, begrenzte Konservierung
Verwendung: Cosyntropin (cortrosyn) is a synthetic derivative of adrenocorticotropic hormone (ACTH) that is used in the ACTH stimulation test to evaluate and diagnose cortisol disorders.
Beschreibung:
Tetrakosaktid (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosactide exhibits the same activity as natural ACTH with regard to all its biological activities. The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.
Anwendung:
In patients with low cortisol levels or symptoms of adrenocortical insufficiency, cosyntropin can be used to diagnose Addison’s disease. A failure for serum cortisol levels to increase after administration of cosyntropin makes a diagnosis of primary adrenocortical insufficiency more likely. An increase in cortisol upon administration of cosyntropin rules out the condition. The test may also be used to assess the function of the adrenal glands after successful treatment for Cushing’s syndrome.
Cosyntropin is also used in the opposite situation, when there is aldosterone hypersecretion due to either a unilateral adrenal adenoma (which is treated by surgical removal) or bilateral adrenal hyperplasia (treated by oral). A procedure called adrenal venous sampling may be used pre-operatively to localize the source of aldosterone hypersecretion from either adrenal gland. A peripheral intravenous infusion of Cosyntropin before and during the procedure stimulates cortisol production and thereby verifies catheter position.
———————————————————————————————————————————————————————————————————————————————————————-
Kontaktieren Sie mich jetzt
Bewertungen
Es gibt noch keine Kommentare.